Alpha 2.0
Login Register
» Journals » EClinicalMedicine

Eclinicalmedicine

EClinicalMedicine is a peer-reviewed open-access journal that publishes high-quality research and clinical studies in all areas of medicine. It aims to provide a platform for disseminating innovative research, promoting evidence-based practice, and advancing healthcare globally. With a focus on digital health, telemedicine, and personalized medicine, the journal strives to bridge the gap between research and clinical practice, fostering collaboration and improving patient outcomes.
Details
Abbr. EClinicalMedicine
Start 2018
End Continuing
e-ISSN 2589-5370
Country United Kingdom
Language English
Specialty General Medicine
Metrics
h-index / Ranks: 4372 80
SJR / Ranks: 455 3522
CiteScore / Ranks: 540 16.00
Recent Articles
31.
Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial
Guchelaar N, Mathijssen R, de Boer M, van Bekkum M, Heijns J, Vriens B, et al.
EClinicalMedicine . 2025 Feb; 80:103065. PMID: 40017682
Background: Effective later-line chemotherapy treatment options are scarce for patients with metastatic breast cancer (MBC). Trifluridine-tipiracil has shown survival benefit in heavily pre-treated patients with metastatic colorectal and in gastric...
32.
Corrigendum for "Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study"
Rui F, Li J
EClinicalMedicine . 2025 Feb; 81:103119. PMID: 40008121
[This corrects the article DOI: 10.1016/j.eclinm.2023.102419.][This corrects the article DOI: 10.1016/j.eclinm.2025.103117.].
33.
Status of cerebrovascular autoregulation relates to outcome in severe paediatric head injury: STARSHIP, a prospective multicentre validation study
Agrawal S, Smith C, Bogli S, Placek M, Cabeleira M, White D, et al.
EClinicalMedicine . 2025 Feb; 81:103077. PMID: 39996125
Background: Continuous assessment of cerebral autoregulation (CA) using pressure reactivity index (PRx), is a promising tool for individualized management to improve outcome after traumatic brain injury (TBI). However, experience with...
34.
Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in early breast cancer post-treatment follow-up (EMINENT): a single-centre, open-label, phase 2, parallel-group, pilot, randomised,...
Chan R, Crawford-Williams F, Han C, Jones L, Chan A, McKavanagh D, et al.
EClinicalMedicine . 2025 Feb; 81:103090. PMID: 39996124
Background: Current models of post-treatment cancer care rely heavily on hospital-based, medical specialists and do not sufficiently leverage primary care. Many breast cancer survivors face ongoing unmet needs that may...
35.
The impact of weight loss interventions on disordered eating symptoms in people with overweight and obesity: a systematic review & meta-analysis
Tsompanaki E, Koutoukidis D, Wren G, Tong H, Theodoulou A, Wang D, et al.
EClinicalMedicine . 2025 Feb; 80:103049. PMID: 39981343
Background: It is unclear whether weight loss interventions worsen disordered eating in people living with overweight/obesity. We aimed to systematically evaluate the association between weight loss interventions and disordered eating....
36.
Performance of ultrasound in detecting fetal hypospadias during pregnancy: a pooled analysis
Zhang Q, Chen H, Wang C, Liu Z, Wei G, Zhang Z, et al.
EClinicalMedicine . 2025 Feb; 81:103091. PMID: 39980698
Background: Opinions regarding the role and value of ultrasound in the diagnosis of prenatal hypospadias are diverse. Although hypospadias is not a fatal malformation, a higher degree of severity exerts...
37.
Unlocking health equity by eliminating copayments for essential antihypertensive medications
Frieden T, Garg R, Banigbe B, Choudhury S, Ogbureke N, Duguma D, et al.
EClinicalMedicine . 2025 Feb; 81:103094. PMID: 39975701
Hypertension kills more people than any other condition; approximately 80% of deaths occur in low- and middle-income countries (LMICs). Only about 1 in 5 adults with hypertension worldwide and less...
38.
Efficacy and safety of immune checkpoint inhibitors in elderly patients with advanced non-small cell lung cancer: a systematic review and meta-analysis
Yao J, Li S, Bai L, Chen J, Ren C, Liu T, et al.
EClinicalMedicine . 2025 Feb; 81:103081. PMID: 39975700
Background: Immune checkpoint inhibitors (ICIs) are the preferred treatments for advanced non-small cell lung cancer (NSCLC) without targetable oncogene alterations. However, evidence in the elderly population (aged ≥ 65 years)...
39.
Occult hepatitis B virus infection: risk for a blood supply, but how about individuals' health?
Fu M, Elsharkawy A, Healy B, Jackson C, Bradshaw D, Watkins E, et al.
EClinicalMedicine . 2025 Feb; 81:103095. PMID: 39975699
The implementation of effective blood donation screening for hepatitis B virus (HBV) anti-core antibodies with highly sensitive molecular HBV DNA detection in low-endemic countries like the United Kingdom has improved...
40.
Risk of aortic aneurysm or dissection following use of fluoroquinolones: a retrospective multinational network cohort study
Janetzki J, Kim J, Minty E, Lee J, Morales D, Khera R, et al.
EClinicalMedicine . 2025 Feb; 81:103096. PMID: 39975698
Background: Fluoroquinolones (FQs) are commonly used to treat urinary tract infections (UTIs), but some studies have suggested they may increase the risk of aortic aneurysm or dissection (AA/AD). However, no...